Home › Funds › KVP Capital Advisors, LP › DRUG

KVP Capital Advisors, LP position in DRUG

BRIGHT MINDS BIOSCIENCES INC · Health Care

KVP Capital Advisors, LP reported holding 31,813 shares of DRUG (BRIGHT MINDS BIOSCIENCES INC) in its Q3 2026 13F filing — a position valued at US$1.6M, representing 1.30% of its reported portfolio and ranking #26 among its reported holdings. KVP Capital Advisors, LP has disclosed DRUG holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

Latest position (Q3 2026)31.81K sh
Reported value held$1.58M
Portfolio Weight1.30%
First reportedQ1 2026
Last changeHold
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How KVP Capital Advisors, LP's DRUG position evolved

KVP Capital Advisors, LP first disclosed a stake in DRUG in Q1 2026 at 31,813 shares (US$2.3M). Across 3 filings, KVP Capital Advisors, LP held the position steady without any share-count change. The most recent filing (Q3 2026) shows 31,813 shares valued at US$1.6M.

Quarter by quarter

QuarterSharesValueChange
Q1 2026 31.81K $2.32M New
Q2 2026 31.81K $2.23M Hold
Q3 2026 31.81K $1.58M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About DRUG and 13F data

DRUG (BRIGHT MINDS BIOSCIENCES INC) is a Health Care company. 64 other funds we track also report a position in DRUG — the largest reported positions include Cormorant Asset Management, LP (US$63.2M), Vestal Point Capital, LP (US$38.3M), BRAIDWELL LP (US$34.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding DRUG

All DRUG fund holders →

FAQ

How long has KVP Capital Advisors, LP held DRUG?

KVP Capital Advisors, LP has disclosed DRUG holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

What is KVP Capital Advisors, LP's current position in DRUG?

As of Q3 2026, KVP Capital Advisors, LP holds 31.81K shares of DRUG (BRIGHT MINDS BIOSCIENCES INC), valued at $1.58M, representing 1.30% of its reported portfolio and ranking #26.

Has KVP Capital Advisors, LP been buying or selling DRUG?

In the latest 13F filing (Q3 2026), KVP Capital Advisors, LP held unchanged its position in DRUG.

Which other funds hold DRUG?

Other major institutional holders of DRUG include Cormorant Asset Management, LP, Vestal Point Capital, LP, BRAIDWELL LP, among 64 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.